Combined targeting of both the TGF-β and PD-1/PD-L1 axis showed synergistic effects, by facilitating T-cell infiltration and potentiation of tumor-reactive T-cells, leading to complete tumor eradication in the majority of treated animals. The gene discussed is CD274; the disease is neoplasm.